Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ad-MAGEA3 |
Trade Name | |
Synonyms | Adenovirus MAGE-A3|AdMA3|MAGE-A3-expressing Adenovirus Type 5 Vaccine |
Drug Descriptions |
Ad-MAGEA3 is a cancer vaccine comprising a replication-defective adenovirus engineered to express MAGE-A3, which may result in enhanced immune response against MAGE-A3 expressing tumors (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C119614 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ad-MAGEA3 | Ad-MAGEA3 | 0 | 0 |
Ad-MAGEA3 + MG1-MAGEA3 + Pembrolizumab | Ad-MAGEA3 MG1-MAGEA3 Pembrolizumab | 0 | 1 |